Peregrine Capital Management’s Haemonetics HAE Stock Holding History

Peregrine Capital Management’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.5M	Buy	59,966 +17,803	+42%	+$1.14M	0.15%	221
2026 Q1	$2.38M	Buy	42,163 +13,553	+47%	+$883K	0.09%	241
2025 Q4	$2.29M	Buy	+28,610	New	+$1.92M	0.07%	245
2025 Q3	–	Sell	-164,341	Closed	-$12.3M	–	345
2025 Q2	$12.3M	Buy	164,341 +2,935	+2%	+$194K	0.37%	57
2025 Q1	$10.3M	Buy	161,406 +19,603	+14%	+$1.33M	0.34%	63
2024 Q4	$11.1M	Buy	141,803 +2,400	+2%	+$193K	0.33%	65
2024 Q3	$11.2M	Buy	139,403 +13,262	+11%	+$1.07M	0.34%	60
2024 Q2	$10.4M	Sell	126,141 -8,462	-6%	-$744K	0.3%	70
2024 Q1	$11.5M	Buy	134,603 +24,290	+22%	+$1.91M	0.33%	63
2023 Q4	$9.43M	Sell	110,313 -18,094	-14%	-$1.56M	0.28%	84
2023 Q3	$11.5M	Sell	128,407 -7,415	-5%	-$662K	0.34%	72
2023 Q2	$11.6M	Sell	135,822 -14,923	-10%	-$1.26M	0.31%	94
2023 Q1	$12.5M	Buy	150,745 +17,406	+13%	+$1.41M	0.36%	75
2022 Q4	$10.5M	Sell	133,339 -16,991	-11%	-$1.37M	0.33%	110
2022 Q3	$11.1M	Sell	150,330 -27,055	-15%	-$1.94M	0.36%	84
2022 Q2	$11.6M	Sell	177,385 -155	-0.1%	-$9.17K	0.35%	95
2022 Q1	$11.2M	Sell	177,540 -13,135	-7%	-$714K	0.27%	153
2021 Q4	$10.1M	Buy	190,675 +5,507	+3%	+$336K	0.2%	198
2021 Q3	$13.1M	Sell	185,168 -23,398	-11%	-$1.48M	0.27%	140
2021 Q2	$13.9M	Buy	+208,566	New	+$14.8M	0.25%	184

Other funds holding HAE

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

CSP

Cary Street Partners Richmond, Virginia $4.58B AUM 24% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

HPCM

Hunter Perkins Capital Management Lombard, Illinois $446M AUM 25.88% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

YCM

Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Peregrine Capital Management's HAE Position: Q2 2026 in Review

Peregrine Capital Management increased its Haemonetics (HAE) stake by 42% in Q2 2026, buying an estimated $1.14M and bringing the position to 59,966 shares worth $4.5M. The position accounts for 0.15% of the portfolio, ranked #221.

Peregrine Capital Management first reported a position in HAE in Q2 2021 and has held it in 20 quarters since. The position peaked at $13.9M in Q2 2021. 31 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

Peregrine Capital Management held 59,966 shares of Haemonetics worth $4.5M as of Q2 2026.
Peregrine Capital Management bought 17,803 Haemonetics shares in Q2 2026, an estimated $1.14M.
Haemonetics made up 0.15% of Peregrine Capital Management's portfolio in Q2 2026, its #221 holding.
Peregrine Capital Management first reported a position in Haemonetics in Q2 2021 and has held it in 20 quarters since.
Peregrine Capital Management's Haemonetics position peaked at $13.9M in Q2 2021.
31 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Peregrine Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.